Skip to content
AiSeekAiSeek
Sign in

4568 TSE

Daiichi Sankyo

FollowOpen structure mapAsk about thisResearch this company

Description

4568 · TSE

Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.

Wikipedia · CC BY-SA 4.0

Headquarters
JP
Website
Website

Structure of Daiichi Sankyo

Daiichi Sankyo

Company

1 connections
UpstreamSupply and dependency
Relationship began2026
Daiichi SankyoCompany · 1 connections
Layer 1

UpstreamSupply and dependency1

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

  • Daiichi Sankyouses →Co-Scientist
    Product · Co-ScientistEvidence 1
    Fact90%
    View evidence
    • CompanyGoogle DeepMind Blog2026-05-17 21:50
      organizations like Daiichi Sankyo, Bayer Crop Science and the U.S. National Labs (as part of the U.S. Department of Energy's Genesis Mission ) are using Co-Scientist to accelerate their research
      View source

Showing 1 to 1 of 1

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1
usesCo-Scientist

organizations like Daiichi Sankyo, Bayer Crop Science and the U.S. National Labs (as part of the U.S. Department of Energy's Genesis Mission ) are using Co-Scientist to accelerate their research

Google DeepMind Blog · 2026-05-17 21:50

View evidence
  • CompanyGoogle DeepMind Blog2026-05-17 21:50
    organizations like Daiichi Sankyo, Bayer Crop Science and the U.S. National Labs (as part of the U.S. Department of Energy's Genesis Mission ) are using Co-Scientist to accelerate their research
    View source

Showing 1 to 1 of 1

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Not available: Company signals · Financials · Filings · Guidance